Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 82,778,520
  • Shares Outstanding, K 335,870
  • Annual Sales, $ 14,571 M
  • Annual Income, $ 14,973 M
  • 36-Month Beta 1.16
  • Price/Sales 5.70
  • Price/Cash Flow 7.60
  • Price/Book 1.18

Price Performance

See More
Period Period Low Period High Performance
1-Month
221.90 +12.17%
on 05/31/17
250.25 -0.54%
on 06/26/17
+25.79 (+11.56%)
since 05/26/17
3-Month
218.60 +13.87%
on 05/18/17
250.25 -0.54%
on 06/26/17
+11.58 (+4.88%)
since 03/24/17
52-Week
184.50 +34.91%
on 11/23/16
261.27 -4.73%
on 07/27/16
+23.19 (+10.27%)
since 06/24/16

Most Recent Stories

More News
Allergan Introduces REFRESH OPTIVE® MEGA-3 Enhanced with Flaxseed Oil, Latest Innovation in the REFRESH® Portfolio

Allergan plc (NYSE: AGN) today announced the launch of the over-the-counter (OTC) artificial tear REFRESH OPTIVE® MEGA-3, the latest innovation in the REFRESH® portfolio that fortifies the lipid layer...

AGN : 248.30 (-0.25%)
Worldwide Facial Injectables Market Drivers, Opportunities, Trends & Forecasts: 2017-2023

Research and Markets has announced the addition of the "Worldwide Facial Injectables MarketDrivers, Opportunities, Trends, and Forecasts: 2017-2023" report to their offering. Skin provides a protective...

VRX.TO : 22.69 (+0.35%)
AGN : 248.30 (-0.25%)
Lannett wins US FDA approval for additional dosage strengths of Hydrocodone Bitartrate and Acetaminophen Tablets USP

Pharmaceutical products company Lannett Company Inc (NYSE:LCI) disclosed on Monday the receipt of approval from the US Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA)...

LCI : 20.48 (-1.06%)
AGN : 248.30 (-0.25%)
Allergan Continues to Focus on Acquisitions and Branded Unit

We issued an updated research report on Allergan plc (AGN) on Jun 23.

AGN : 248.30 (-0.25%)
TEVA : 32.75 (-0.61%)
RHHBY : 32.6200 (+0.46%)
AMGN : 173.02 (-0.37%)
Lannett Receives Approval For Additional Dosage Strengths Of Hydrocodone Bitartrate And Acetaminophen Tablets USP

Lannett Company, Inc. (NYSE: LCI) today announced that it received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Hydrocodone Bitartrate and...

LCI : 20.48 (-1.06%)
AGN : 248.30 (-0.25%)
Top Stock Reports for Oracle, Allergan & Abbott

Top Stock Reports for Oracle, Allergan & Abbott

ABT : 48.91 (+0.04%)
VLO : 66.22 (+0.27%)
AGN : 248.30 (-0.25%)
ADBE : 144.05 (-0.63%)
ORCL : 50.77 (-0.18%)
ALXN : 125.58 (+0.39%)
Facial Injectables Market to Reach $17.2 Billion by 2025 - Analysis By Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers)

Research and Markets has announced the addition of the "Facial Injectables Market Analysis By Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), By Application...

ANIK : 48.97 (-0.02%)
AGN : 248.30 (-0.25%)
Global Chronic Kidney Disease (CKD) Drugs Market to Reach $17.4 Billion by 2025 - Analysis By Drug Class & Geography

Research and Markets has announced the addition of the "Global Chronic Kidney Disease (CKD) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...

KSPHF : 27.4271 (unch)
KERX : 6.89 (-0.86%)
JNJ : 135.99 (-0.26%)
AGN : 248.30 (-0.25%)
TEVA : 32.75 (-0.61%)
AMGN : 173.02 (-0.37%)
PFE : 33.90 (-0.41%)
Global Tinea Pedis Treatment Market to Grow at a CAGR of 3% by 2021 - Key Vendors are GSK, Exeltis USA, Valeant & Viamet Pharmaceuticals

Research and Markets has announced the addition of the "Global Tinea Pedis Treatment Market 2017-2021" report to their offering. The global tinea pedis treatment market to grow at a CAGR of 3.03% during...

AGN : 248.30 (-0.25%)
AMGN : 173.02 (-0.37%)
CELGZ : 1.14 (unch)
BMY : 56.62 (-0.53%)
Global Markets for Allergy Diagnostics and Treatments - Expected to Increase from Nearly $40.0 Billion in 2016 to $52.7 Billion in 2021

Research and Markets has announced the addition of the "Global Markets for Allergy Diagnostics and Treatments" report to their offering. This report is designed to provide a comprehensive look at the...

BMRA : 2.54 (+1.60%)
ALR : 50.25 (+0.08%)
JNJ : 135.99 (-0.26%)
AGN : 248.30 (-0.25%)
LH : 151.25 (-0.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Support & Resistance

2nd Resistance Point 252.18
1st Resistance Point 250.55
Last Price 248.30
1st Support Level 246.98
2nd Support Level 245.04

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.